Clinical and economic benefits of image-guided system in functional endoscopicsinus surgery: a retrospective chart review study in China.
Clinical and economic benefits
Functional endoscopic sinus surgery
Image-guided system
Journal
Cost effectiveness and resource allocation : C/E
ISSN: 1478-7547
Titre abrégé: Cost Eff Resour Alloc
Pays: England
ID NLM: 101170476
Informations de publication
Date de publication:
12 Jan 2023
12 Jan 2023
Historique:
received:
20
07
2022
accepted:
03
01
2023
entrez:
12
1
2023
pubmed:
13
1
2023
medline:
13
1
2023
Statut:
epublish
Résumé
Image-guided system (IGS) has been gradually applied in the field of rhinology, making functional endoscopic sinus surgery (FESS) a truly minimally invasive and precise surgery. This study was based on real-world data from China hospitals and aimed to evaluate the clinical and economic benefits of the IGS navigation system in FESS. This was a two-center retrospective chart review of patients with chronic rhinosinusitis who underwent FESS, including open frontal sinus between July 1, 2018 and December 31, 2019 in China. The intervention group consisted of 100 patients who underwent FESS with the IGS navigation system (IGS group), and the control group consisted of 100 patients who underwent conventional FESS (Non-IGS group). Data were collected from surgical notes and hospital medical records. The primary endpoints for clinical effectiveness and safety were avoid rehospitalization due to bleeding, avoid reoperation due to bleeding, and avoid reoperation due to recurrence. There were no cases of rehospitalization due to bleeding, reoperation due to bleeding, and reoperation due to recurrence in the IGS group, with an avoidance rate of 100%. In the non-IGS group, there were four cases of rehospitalization and reoperation due to bleeding, with an avoidance rate 96.00% (P = 0.121). No cases of reoperation due to recurrence were in the non-IGS group. The total hospitalization cost was 17,391.51 CNY in the IGS group and 17,742.41 CNY in the non-IGS group per patient, with no statistical difference between the two groups (P = 0.715). Compared with the non-IGS group, the IGS group had an overall cost saving of 350.90 CNY per patient. Although the procedure-related medical costs of IGS group were increased by 1,286.12 CNY compared with the non-IGS group, this was more than offset by other costs. The results of the study indicated that the IGS may avoid occurrence of rehospitalization and reoperation due to postoperative bleeding. Although the use of navigation technology increased the cost of surgery, its clinical effectiveness brought other medical cost savings, resulting in no significant difference in the overall cost of navigation surgery compared to conventional surgery. The IGS should be considered cost-effectiveness in the treatment of FESS.
Sections du résumé
BACKGROUND
BACKGROUND
Image-guided system (IGS) has been gradually applied in the field of rhinology, making functional endoscopic sinus surgery (FESS) a truly minimally invasive and precise surgery. This study was based on real-world data from China hospitals and aimed to evaluate the clinical and economic benefits of the IGS navigation system in FESS.
METHODS
METHODS
This was a two-center retrospective chart review of patients with chronic rhinosinusitis who underwent FESS, including open frontal sinus between July 1, 2018 and December 31, 2019 in China. The intervention group consisted of 100 patients who underwent FESS with the IGS navigation system (IGS group), and the control group consisted of 100 patients who underwent conventional FESS (Non-IGS group). Data were collected from surgical notes and hospital medical records. The primary endpoints for clinical effectiveness and safety were avoid rehospitalization due to bleeding, avoid reoperation due to bleeding, and avoid reoperation due to recurrence.
RESULTS
RESULTS
There were no cases of rehospitalization due to bleeding, reoperation due to bleeding, and reoperation due to recurrence in the IGS group, with an avoidance rate of 100%. In the non-IGS group, there were four cases of rehospitalization and reoperation due to bleeding, with an avoidance rate 96.00% (P = 0.121). No cases of reoperation due to recurrence were in the non-IGS group. The total hospitalization cost was 17,391.51 CNY in the IGS group and 17,742.41 CNY in the non-IGS group per patient, with no statistical difference between the two groups (P = 0.715). Compared with the non-IGS group, the IGS group had an overall cost saving of 350.90 CNY per patient. Although the procedure-related medical costs of IGS group were increased by 1,286.12 CNY compared with the non-IGS group, this was more than offset by other costs.
CONCLUSION
CONCLUSIONS
The results of the study indicated that the IGS may avoid occurrence of rehospitalization and reoperation due to postoperative bleeding. Although the use of navigation technology increased the cost of surgery, its clinical effectiveness brought other medical cost savings, resulting in no significant difference in the overall cost of navigation surgery compared to conventional surgery. The IGS should be considered cost-effectiveness in the treatment of FESS.
Identifiants
pubmed: 36635702
doi: 10.1186/s12962-023-00414-2
pii: 10.1186/s12962-023-00414-2
pmc: PMC9837985
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1Informations de copyright
© 2023. The Author(s).
Références
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Mar;32(5):321-324
pubmed: 29798285
Rhinology. 2020 Apr 1;58(2):82-111
pubmed: 32226949
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Aug;29(16):1431-4
pubmed: 26665449
Qual Life Res. 2003 Jun;12(4):443-8
pubmed: 12797716
Int Forum Allergy Rhinol. 2013 Mar;3(3):236-41
pubmed: 23044799
Am J Rhinol. 2001 Mar-Apr;15(2):71-5
pubmed: 11345156
Int Forum Allergy Rhinol. 2012 Jan-Feb;2(1):34-9
pubmed: 22311839
J Laryngol Otol. 2010 May;124(5):500-4
pubmed: 20003603
Am J Rhinol. 2002 Jul-Aug;16(4):193-7
pubmed: 12222943
Otolaryngol Head Neck Surg. 2013 Jul;149(1):17-29
pubmed: 23678278
Laryngoscope. 2021 Oct;131(10):2169-2172
pubmed: 33606274
Allergy Rhinol (Providence). 2014 Jan;5(3):116-9
pubmed: 25565045
Ann Otol Rhinol Laryngol Suppl. 2004 May;193:3-5
pubmed: 15174752
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Feb 7;54(2):81-100
pubmed: 30776860
Otolaryngol Head Neck Surg. 2006 Jul;135(1):68-73
pubmed: 16815185